NXG NexgenRx Inc.

0.4126USD0.5900 CAD · TSXV-11.94%Mkt Cap: 29.34M USDP/E: 19.67

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims…

Key Statistics

Company
Market Cap29.34M USD
Enterprise Value28.20M USD
Revenue (TTM)13.53M USD
Gross Profit10.44M USD
Net Income (TTM)901.89K USD
Revenue/Share0.18 USD
Last Price0.4126 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryHealth Information Services
ISINCA65337X1042
Valuation
P/E (Trailing)19.67
P/E (Forward)—
PEG6.53
EV/EBITDA12.14
EV/Revenue2.08
P/S2.17
P/B5.41
EPS (TTM)0.02 USD
EPS (Forward)—
52W Range
0.202865% of range0.5245
52W High0.5245 USD
52W Low0.2028 USD
Profitability
Gross Margin83.28%
Oper. Margin18.70%
EBITDA Margin17.18%
Profit Margin7.19%
ROE16.92%
ROA3.52%
ROIC46.35%
ROCE28.24%
Growth
Revenue Growth20.80%
Earnings Growth140.00%
Cash Flow & Leverage
Operating CF3.48M USD
CapEx (TTM)241.27K USD
FCF Margin9.35%
FCF Yield4.31%
Net Debt-2.30M USD
Net Debt/EBITDA-0.99
Net Debt/FCF-1.82
Balance Sheet
Debt/Equity0.05
Current Ratio1.15
Quick Ratio0.19
Book Value/Sh0.08 USD
Cash/Share0.03 USD
Dividends
Fwd Div Rate0.01 USD
Trail. Div Rate0.01 USD
Div. Yield2.99%
5Y Avg Yield2.53%
Payout Ratio48.39%
Ex-Div DateNov 2, 2026
Pay DateNov 4, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.12M
Float44.81M
Insiders36.98%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short2.90K
Short (prev mo.)904
Technical
SMA 500.4480 (-7.9%)
SMA 2000.3452 (+19.5%)
Beta0.43
S&P 52W Chg12.00%
Avg Vol (30d)20.13K
Avg Vol (10d)10.07K
Technical Indicators
RSI (14)40.3
MACD0.0069
MACD Signal0.0143
MACD Hist.-0.0073
BB Upper0.5154 USD
BB Middle0.4668 USD
BB Lower0.4181 USD
BB Width20.84%
ATR (14)0.0234 USD
Vol Ratio (20d)6.00x

About NexgenRx (CVE: NXG)

›

NexgenRx (CVE: NXG) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.

The shares were at 0.5900 CAD on 19 November 2026, up 51.6% over 52 weeks. Its 52-week range is 0.2900 CAD to 0.7500 CAD: the price is 21.3% below the high and 103.4% above the low.

At a market capitalisation of 41.96M CAD, it trades at 19.7 times trailing earnings. The median trailing P/E of its 15 largest Health Information Services peers is 39.9, a discount of 51% for NXG. It pays a dividend yielding 2.99% (it pays out 48% of its earnings), against a median of 0.53% among the dividend payers in that peer group.

NexgenRx reports return on equity of 16.9%, an operating margin of 18.7% and revenue up 20.8% year over year.

It holds more cash than debt, a net cash position of 3.29M CAD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. The next earnings report is expected on 26 November 2026.